May 11, 2026
39:38
For every 38 shares held, investors received 39. The price per share adjusted from $3.25 to $3.17.
The split itself did not change the total investment value.
Elicera Therapeutics AB (STO:ELIC) operates in the Biotechnology industry.
Elicera Therapeutics AB company overviewElicera Therapeutics AB's most recent stock split was on May 11, 2026. It was a 39-for-38 forward split, so shareholders received 39 shares for every 38 they held.
Elicera Therapeutics AB has split its stock once. This history records one forward split, on May 11, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Elicera Therapeutics AB's 39-for-38 split on May 11, 2026, every 38 shares became 39 shares.
Elicera Therapeutics AB has not announced a new split in our records. Its most recent split was on May 11, 2026, less than a year ago. Companies announce splits in advance, and any new STO:ELIC split will appear on this page.
Already premium?